Development and Anti-tumor Study of Bispecific Antibody Drug Conjugate Targeting TPBG and EGFR

JIN Mei-qin, SHANG Cheng-zhang, SHEN Yue-lei

China Biotechnology ›› 2023, Vol. 43 ›› Issue (5) : 11-23.

PDF(2884 KB)
PDF(2884 KB)
China Biotechnology ›› 2023, Vol. 43 ›› Issue (5) : 11-23. DOI: 10.13523/j.cb.2212010

Development and Anti-tumor Study of Bispecific Antibody Drug Conjugate Targeting TPBG and EGFR

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 43(5): 11-23 https://doi.org/10.13523/j.cb.2212010

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2884 KB)

Accesses

Citation

Detail

Sections
Recommended

/